Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

5.745 -0.085 (-1.46%)
Streaming Delayed Price Updated: 9:45 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
From MannKind
Via GlobeNewswire
News headline image
MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
From MannKind
Via GlobeNewswire
News headline image
Why MannKind Stock Soared 19% Higher on Tuesday ↗
The biotech delivered quite an impressive earnings report. 
Via The Motley Fool
News headline image
MannKind (MNKD) Q2 2023 Earnings Call Transcript ↗
MNKD earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Earnings Preview For MannKind ↗
 
Via Benzinga
News headline image
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback' ↗
Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗
 
Via Benzinga
News headline image
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth ↗
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
Via InvestorPlace
News headline image
Why Shares of MannKind Are Up Wednesday ↗
The company released its first-quarter earnings report on Tuesday. 
Via The Motley Fool
News headline image
MannKind (MNKD) Q1 2023 Earnings Call Transcript ↗
MNKD earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
MannKind: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
MannKind Corporation Announces Participation at Upcoming Conferences
From MannKind
Via GlobeNewswire
News headline image
3 Biotech Stocks to Sell in August Before They Crash and Burn ↗
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. 
Via InvestorPlace
News headline image
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday ↗
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst Justin Patterson maintained an Overweight rating. Bumble shares rose 0.9% to $16.65 in pre-market... 
Via Benzinga
News headline image
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
News headline image
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
News headline image
MannKind Corporation Reports 2023 Second Quarter Financial Results
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023
From MannKind
Via GlobeNewswire
News headline image
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now ↗
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options. 
Via InvestorPlace
News headline image
7 Biotech Stocks to Sell in July ↗
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
News headline image
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)
From MannKind
Via GlobeNewswire
News headline image
7 Overvalued Penny Stocks to Sell Before June 2023 ↗
It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable. 
Via InvestorPlace
News headline image
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer
From MannKind
Via GlobeNewswire
News headline image
3 Biotech Stocks to Avoid Like the Plague ↗
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
News headline image
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
News headline image
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
From MannKind
Via GlobeNewswire
News headline image
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET) 
From MannKind
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.